| A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept JA Cruz-Cardenas, M Gutierrez, A López-Arredondo, ... Scientific Reports 12 (1), 17966, 2022 | 26 | 2022 |
| Neutrophils, an emerging new therapeutic platform A López-Arredondo, JA Cruz-Cardenas, JA Cázares-Preciado, ... Current Opinion in Biotechnology 87, 103106, 2024 | 1 | 2024 |
| First pseudovirus-based assay to measure virus-elicited neutralizing antibodies in Mexico: proof-of-concept with SARS-CoV-2 JA Cruz-Cardenas, MGM Gutierrez-Mayret, A López-Arredondo, ... | 1 | 2022 |
| Metabolic features of neutrophilic differentiation of HL-60 cells in hyperglycemic environments JA Cázares-Preciado, A López-Arredondo, JA Cruz-Cardenas, ... BMJ Open Diabetes Research and Care 12 (4), e004181, 2024 | | 2024 |
| A pseudotyped lentivirus-based assay to titer SARS-CoV-2 neutralizing antibodies in Mexico JA Cruz-Cardenas, M Gutierrez-Mayret, A López-Arredondo, ... bioRxiv, 2022.01. 27.478128, 2022 | | 2022 |
| XX Congreso Nacional de Biotecnología y Bioingeniería A López-Arredondo, JA Cruz-Cardenas, MEG Brunck | | |
